IS THERE A CASE FOR PAF ANTAGONISTS IN THE TREATMENT OF ISCHEMIC STATES

被引：151

作者：

BRAQUET, P

PAUBERTBRAQUET, M

KOLTAI, M

BOURGAIN, R

BUSSOLINO, F

HOSFORD, D

机构：

[1] HOP INSTRUCT ARMEES PERCY,CTR BURNS,CLIN RES UNIT,F-92141 CLAMART,FRANCE

[2] VUB BRUSSELS,FYSIOL & FYSIOPATHOL LAB,B-1090 BRUSSELS,BELGIUM

[3] INST IGIENE,CATTEDRA CHIM & PROPEDEUT BIOCHIM,I-10126 TURIN,ITALY

来源：

关键词：

D O I：

10.1016/0165-6147(89)90103-X

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：23 / 30

页数：8

共 38 条

[1] BERKAW RL, 1986, BLOOD, V68, pA80
[2] BIRKLE DL, IN PRESS J NEUROCHEM
[3] EFFECT OF PLATELET-ACTIVATING FACTOR ON MONOCYTE ACTIVATION AND PRODUCTION OF TUMOR NECROSIS FACTOR
BONAVIDA, B
MENCIAHUERTA, JM
BRAQUET, P
[J]. INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1989, 88 (1-2): : 157 - 160
[4] THE EFFECT OF 1-O-ALKYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE (PAF-ACETHER) ON THE ARTERIAL-WALL
BOURGAIN, RH
MAES, L
BRAQUET, P
ANDRIES, R
TOUQUI, L
BRAQUET, M
[J]. PROSTAGLANDINS, 1985, 30 (02): : 185 - 197
[5] BRAQUET P, 1987, PHARMACOL REV, V39, P97
[6] PAF-ACETHER SPECIFIC BINDING-SITES .2. DESIGN OF SPECIFIC ANTAGONISTS
BRAQUET, P
GODFROID, JJ
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (10) : 397 - 403
[7] BRAQUET P, 1989, INT ARCH ALLER A IMM, V88, P89
[8] BUSSOLINO F, 1988, J BIOL CHEM, V263, P11856
[9] CANNISTRA SA, 1988, BLOOD, V71, P672
[10] LEUKOTRIENE PRODUCTION IN HUMAN-NEUTROPHILS PRIMED BY RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR AND STIMULATED WITH THE COMPLEMENT COMPONENT C5A AND FMLP AS 2ND SIGNALS
DAHINDEN, CA
ZINGG, J
MALY, FE
DEWECK, AL
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (04) : 1281 - 1295